Информационный дайджест: Обзор регуляторных изменений в сфере доступа к рынку, здравоохранения и фармы в странах региона Восточной Европы, СНГ, Центральной Азии за январь 2021 на английском языке.

UPharma Consulting rolls-out its brand-new series of pharmaceutical market access reports covering all Eastern European, Central Asian, South Caucasian, CIS, and other countries. The current Report—Ukraine Pharmaceutical Market Access Pathway 2020 FY ("Report")—is focused on Ukraine. The publication uncovers all aspects of accessing the market for pharmaceuticals: marketing authorization, pricing and reimbursement in Ukraine, essential medicines and national formulary listings, public purchase procedures, requirements, and stakeholders mapping, price regulation, health technology assessment.

UPharma Consulting launches its updated series of pharmaceutical country reports covering all Eastern European, Central Asian, South Caucasian, CIS, and other countries. The current Report—Ukraine Pharmaceutical Country Report 2020 FY ("Report")—is focused on Ukraine. This publication depicts the latest 2019-2020 FY business trends of Ukraine's pharmaceutical market, uncovers the market access pathway for pharmaceutical products in the country: from marketing authorization to essential medicines and national formulary listings. It provides a forecast of total pharmaceutical market sales for the next three years (2021-2023), considering all the COVID-19-concerned crisis implications.

Данная публикация раскрывает основные характеристики регулирования фармацевтических рынков в семи странах СНГ. "CIS Pharmaceutical Markets Legal Environment" охватывает вопросы регистрации лекарственных средств, импортного контроля, регулирования цен и продвижения фармацевтической продукции.

We are happy to announce our new report is launched: "Armenia Pharmaceutical & Healthcare Industries Overview 2018". The report comprises the overview of Armenian economic, pharmaceutical and healthcare latest trends in a tailored made systematic and business styled manner. The Overview was developed for decision makers and industry professionals, life sciences stakeholders globally. It covers the 2012-1HY 2017 historical data with the forecast of the economics and pharmaceutical market numbers to 2018-2019.